Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol

por Roskell, Neil S, Anzueto, Antonio, Hamilton, Alan, Disse, Bernd, Becker, Karin
Publicado 2014

Efficacy and safety of tiotropium Respimat(®) SMI in COPD in two 1-year randomized studies

por Bateman, Eric, Singh, Dave, Smith, David, Disse, Bernd, Towse, Lesley, Massey, Dan, Blatchford, Jon, Pavia, Demetri, Hodder, Rick
Publicado 2010

Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease

por Rodriguez-Roisin, Roberto, Tetzlaff, Kay, Watz, Henrik, Wouters, Emiel FM, Disse, Bernd, Finnigan, Helen, Magnussen, Helgo, Calverley, Peter MA
Publicado 2016

The Tiotropium Safety and Performance in Respimat® Trial (TIOSPIR®), a large scale, randomized, controlled, parallel-group trial-design and rationale

por Wise, Robert A, Anzueto, Antonio, Calverley, Peter, Dahl, Ronald, Dusser, Daniel, Pledger, Gordon, Koenen-Bergmann, Michael, Joseph, Elizabeth, Cotton, Daniel, Disse, Bernd
Publicado 2013